Related Experiment Video
Updated: Oct 16, 2026

Isolation of Human Endometrial Stromal Cells for In Vitro Decidualization
Published on: September 1, 2018
Abnormal cell differentiation and p21 expression of endometrial epithelial cells following developmental exposure to
A Yoshida1, R R Newbold, D Dixon
1Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.
Abstract:
Gene expression relevant to abnormal cell differentiation and altered cell cycle in endometrial epithelial cells was investigated immunohistochemically in developing mouse uteri exposed neonatally to diethylstilbestrol (DES). Female CD-1 mice were given daily s.c. injections of 2 microg of DES in corn oil or were given corn oil alone (control) at 1-5 days of age and euthanatized at 5, 6, 7, 8, 15, and 22 days of age. The endometrial epithelial cells of DES-treated mice at 5-8 days of age showed enhanced staining intensity for the estrogen receptor alpha (ER alpha), whereas the stromal cells showed decreased staining reaction; the epithelial cells showed that the protein encoded by the c-fos proto-oncogene, which plays a key role in regulating diverse estrogen-related cellular differentiation patterns, was enhanced. These cells also showed increased expression of lactoferrin, a sensitive protein marker of estrogen exposure, although the staining intensity decreased after exposure ended. The stain for p21 protein, a mitotic inhibitor which suppresses cyclin-dependent kinase activity, showed frequent positively stained cells in DES-treated mice at 5-15 days of age, whereas no accumulation of p53 protein of either wild or mutant type was detected immunohistochemically in these cells. These results indicate that suppressed cell cycle activity of endometrial epithelial cells and abnormal estrogen-related differentiation at the developmental stage following neonatal DES exposure may be caused, in part, by transient altered expression of ER alpha and expression of the p21 gene, which appears to be induced by a p53-independent mechanism.
Insights
Neonatal exposure to diethylstilbestrol (DES) in mice altered endometrial cell differentiation and cell cycle. These changes were linked to modified estrogen receptor alpha (ER alpha) and p21 gene expression, independent of p53.
Area of Science:
- Endocrinology
- Developmental Biology
- Molecular Biology
Background:
- Neonatal exposure to endocrine-disrupting chemicals can lead to long-term reproductive health issues.
- Diethylstilbestrol (DES) is a synthetic estrogen with known developmental toxicity.
- Understanding gene expression changes in response to neonatal DES exposure is crucial for assessing risks.
Purpose of the Study:
- To investigate the effects of neonatal diethylstilbestrol (DES) exposure on gene expression related to cell differentiation and cell cycle in mouse endometrial epithelial cells.
- To identify specific molecular mechanisms underlying DES-induced abnormalities in the developing uterus.
Main Methods:
- Immunohistochemical analysis was performed on mouse uteri from 5 to 22 days of age.
- Mice received daily subcutaneous injections of DES or corn oil (control) from postnatal days 1-5.
- Expression levels of estrogen receptor alpha (ER alpha), c-fos, lactoferrin, p21, and p53 proteins were assessed.
Main Results:
- Neonatal DES exposure enhanced ER alpha and c-fos expression in endometrial epithelial cells at 5-8 days of age.
- Increased lactoferrin expression, a marker of estrogen exposure, was observed, though it decreased after DES cessation.
- Frequent p21 protein staining, a mitotic inhibitor, was noted in DES-treated mice (5-15 days), while p53 accumulation was not detected.
Conclusions:
- Neonatal DES exposure can cause suppressed cell cycle activity and abnormal estrogen-related differentiation in endometrial epithelial cells.
- Transient alterations in ER alpha expression and p21 gene induction, via a p53-independent pathway, may contribute to these developmental effects.
- These findings highlight the potential for early-life exposure to endocrine disruptors to impact uterine development and function.
Related Concept Videos
Abnormal Proliferation
Cellular Adaptation IV: Dysplasia and Metaplasia
Oogenesis
